Ledger.Open graph →
SEC Form D · filed December 13, 2017

Kv1.3 Therapeutics, Inc

Offering
$5.0M
Sold
$16K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Llew J. Keltner · San Francisco, CADirectorRichard W. Pascoe · Celebration, FLDirectorRichard J. Nesbit · San Francisco, CADirectorJoshua W. Kriesel · San Francisco, CADirectorMichael Hanrahan · Downers Grove, ILDirectorDaniel Raymond · Seattle, WADirectorLord Farmer · LONDON, United KingdomDirectorSven L. Guenther · Celebration, FLDirectorShawn Iadonato · Seattle, WADirectorJoseph B. Saluri · Celebration, FLDirectorLucien Fouke · Seattle, WADirectorDaniel J. Tasse · San Francisco, CADirectorGavin Jancke · SEATTLE, WADirectorPaul G. Coughlan · London, United KingdomExecRon W. Pauli · San Francisco, CADirectorRobert Hedequist · Seattle, WADirectorStephen F. Mahedy · Beltsville, MDExecCraig Philips · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗